FDA Targets ‘Disease Areas’ for Patient-Centered Research Push

Washington Drug Letter
A A
Acting on a mandate of the most recent user fee framework, the FDA has selected more than a dozen disease areas it plans to address as part of a new initiative on patient-centered research through 2015.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00